Differences

This shows you the differences between two versions of the page.

--- covid-19:treatments:drug_therapies:ivermectin [2021/12/31 20:09]
sage [Link Dump]
+++ covid-19:treatments:drug_therapies:ivermectin [2023/05/04 18:10] (current)
gabriel [Link Dump]
@@ Line 3: / Line 3: @@
 ===== Educational Content =====
-[[https://www.youtube.com/watch?v=OLxJUOc_p5o|The Ivermectin Story]] with forward by Dr. [[:Pierre Kory]] of the [[:FLCCC]].
+The Ivermectin Story with a forward by Dr. [[:Pierre Kory]] of the [[:FLCCC]].(([[https://www.youtube.com/watch?v=OLxJUOc_p5o|Video]]))
+Pierre Kory (again!) with a timely update on the whole ivermectin picture, published on January 6, 2022.((https://pierrekory.substack.com/p/the-global-disinformation-campaign?))
 ===== Rationale =====
   * Probable mechanisms of action of ivermectin against [[:SARS-CoV-2]].(([[:The Journal of Antibiotics]] | Asiya Kamber Zaidi & Pya Dehgani-Mobaraki | [[https://www.nature.com/articles/s41429-021-00491-6|The mechanisms of action of ivermectin against SARS-CoV-2—an extensive review]]))
@@ Line 16: / Line 17: @@
 ==== Prophylaxis Research ====
+October 28, 2021: 'Ivermectin Prophylaxis Survey of 306 Health Care Workers in India' by Ajay Kumar Verma et. al., published in the //Indian Journal of Community Health//
+(([[http://www.iapsmupuk.org/journal/index.php/IJCH/article/view/2221|Assessing Knowledge, Attitude, and Practices towards Ivermectin Pre-exposure Prophylaxis for COVID-19 among Health Care Workers.]]))
+January 15, 2022: 'Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching' Kerr L, Cadegiani F A, Baldi F, et al. (January 15, 2022) Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching. Cureus 14(1): e21272. doi:10.7759/cureus.21272((https://www.cureus.com/articles/82162-ivermectin-prophylaxis-used-for-covid-19-a-citywide-prospective-observational-study-of-223128-subjects-using-propensity-score-matching))
+“When adjusted for residual variables, reduction in mortality rate was 70%. After adjustment for residual variables, reduction in hospitalization rate was 67%.
+Conclusion: In this large PSM study, regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.”
+==== Therapeutic Research ====
+Retrospective analysis of 92 severe Covid-19 patients by Dr. Jackie Stone et. al., pre-print posted on 09 Nov, 2021.(([[https://www.researchsquare.com/article/rs-1048271/v1|
+Rapid increase of SpO2 on room air for 34 severe COVID-19 patients after ivermectin-based combination treatment: 55-62% normalization within 12-24 hours]]))
-==== Therapeudic Research ====
-Retrospective analysis of 92 severe Covid-19 patients\\ by Dr. Jackie Stone et. al\\ pre-print posted on 09 Nov, 2021\\
-[[https://www.researchsquare.com/article/rs-1048271/v1|
-Rapid increase of SpO2 on room air for 34 severe COVID-19 patients after ivermectin-based combination treatment: 55-62% normalization within 12-24 hours]]
-Ivermectin [[Prophylaxis]] Survey of 306 Health Care Workers in India\\ by Ajay Kumar Verma et. al. \\ Published in the //Indian Journal of Community Health// October 28, 2021\\
-[[http://www.iapsmupuk.org/journal/index.php/IJCH/article/view/2221|Assessing Knowledge, Attitude, and Practices towards Ivermectin Pre-exposure Prophylaxis for COVID-19 among Health Care Workers.]]
 ==== Meta-Analyses of Ivermectin Efficacy ====
@@ Line 169: / Line 176: @@
 Alexandros Marinos rebuttal to Scott Alexander piece:
 https://doyourownresearch.substack.com/p/a-conflict-of-blurred-visions?showWelcome=true
+Australia Removal of prescribing restrictions on ivermectin https://www.tga.gov.au/news/media-releases/removal-prescribing-restrictions-ivermectin